Qineng Ping

Qineng Ping


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Biomaterials
Verified
Journal Article
Closed access
HQHongzhi Qiao
Hongzhi Qiao
MSMinjie Sun
Minjie Sun
ZSZhigui Su
Zhigui Su
YXYing Xie
Ying Xie
MCMinglei Chen
Minglei Chen
QPQineng Ping
Qineng Ping

1 December 2014 in Journal of Controlled Release
Verified
Journal Article
Closed access
ZSZhigui Su
Zhigui Su
MCMinglei Chen
Minglei Chen
YXYanyu Xiao
Yanyu Xiao
MSMinjie Sun
Minjie Sun
LZLi Zong
Li Zong
CZCan Zhang
Can Zhang

1 September 2016 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
HLHuipeng Li
Huipeng Li
MCMinglei Chen
Minglei Chen
ZSZhigui Su
Zhigui Su
MSMinjie Sun
Minjie Sun
QPQineng Ping
Qineng Ping

6 November 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MCMinglei Chen
Minglei Chen
KJKambere Amerigos Daddy J.C.
Kambere Amerigos Daddy J.C.
ZSZhigui Su
Zhigui Su
NGNida El Islem Guissi
Nida El Islem Guissi
YXYanyu Xiao
Yanyu Xiao
QPQineng Ping
Qineng Ping
Multifunctional nanomedicines with active targeting and stimuli-responsive drug release function utilizing pathophysiological features of the disease are regarded as an effective strategy for treatment of rheumatoid arthritis (RA). Under the inflammatory environment of RA, activated macrophages revealed increased expression of folate receptor and elevated intracellular reactive oxygen species (ROS) level. In this study, we successfully conjugated folate to polyethylene glycol 100 monostearate as film-forming material and further prepared methotrexate (MTX) and catalase (CAT) co-encapsulated liposomes, herein, shortened to FOL-MTX&CAT-L, that could actively target to activated macrophages. Thereafter, elevated intracellular hydrogen peroxide, the main source of ROS, diffused into liposomes and encapsulated CAT catalyzed the decomposition of hydrogen peroxide into oxygen and water. Continuous oxygen-generation inside liposomes would eventually disorganize its structure and release the encapsulated MTX. We characterized the in vitro drug release, cellular uptake and cytotoxicity studies as well as in vivo pharmacokinetics, biodistribution, therapeutic efficacy and safety studies of FOL-MTX&CAT-L. In vitro results revealed that FOL-MTX&CAT-L possessed sufficient ROS-sensitive drug release, displayed an improved cellular uptake through folate-mediated endocytosis and exhibited a higher cytotoxic effect on activated RAW264.7 cells. Moreover, in vivo results showed prolonged blood circulation time of PEGylated liposomes, enhanced accumulation of MTX in inflamed joints of collagen-induced arthritis (CIA) mice, reinforced therapeutic efficacy and minimal toxicity toward major organs. These results imply that FOL-MTX&CAT-L may be used as an effective nanomedicine system for RA treatment.

1 January 2017 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
MCMinglei Chen
Minglei Chen
KJKambere Amerigos Daddy J.C.
Kambere Amerigos Daddy J.C.
YXYanyu Xiao
Yanyu Xiao
QPQineng Ping
Qineng Ping
LZLi Zong
Li Zong
Rheumatoid arthritis (RA) is characterized by synovial inflammation and hyperplasia, autoantibody production, cartilage and bone destruction, and systemic features including cardiovascular, pulmona...

4 July 2016 in Biological Research
Verified
Journal Article
Open access
PDF file
XCXuebing Cao
Xuebing Cao
DHDongzhi Hou
Dongzhi Hou
LWLei Wang
Lei Wang
SLSai Li
Sai Li
SSShengang Sun
Shengang Sun
YXYan Xu
Yan Xu
Chitosan, the N-deacetylated derivative of chitin, is a cationic polyelectrolyte due to the presence of amino groups, one of the few occurring in nature. The use of chitosan in protein and drug delivery systems is being actively researched and reported in the literature. In this study, we used chitosan-coated levodopa liposomes to investigate the behavioral character and the expression of phosphorylated extracellular signal-regulated kinase (ERK1/2), dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32) and FosB/ΔFosB in striatum of rat model of levodopa-induced dyskinesia (LID). We found that scores of abnormal involuntary movement (AIM) decreased significantly in liposome group (P < 0.05), compared with levodopa group. Levels of phospho-ERK1/2, phospho-Thr34 DARPP-32 and FosB/ΔFosB in striatum decreased significantly in liposome group lesion side compared with levodopa group (P < 0.05). However, both of two groups above have significantly differences compared with the control group (P < 0.05). Chitosan-coated levodopa liposomes may be useful in reducing dyskinesias inducing for Parkinson disease. The mechanism might be involved the pathway of signaling molecular phospho-ERK1/2, phospho-Thr34 DARPP-32 and ΔFosB in striatum.